Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency | Zendy

Andrea Ciorba | Zendy; Piotr H. Skarżyński | Zendy; Stefano Pelucchi | Zendy; Stavros Hatzopoulos | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency

Author(s) -

Andrea Ciorba,

Piotr H. Skarżyński,

Stefano Pelucchi,

Stavros Hatzopoulos

Publication year - 2020

Publication title -

journal of global antimicrobial resistance

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.917

H-Index - 26

eISSN - 2213-7173

pISSN - 2213-7165

DOI - 10.1016/j.jgar.2020.09.030

Subject(s) - hydroxychloroquine , chloroquine , ototoxicity , pandemic , covid-19 , medicine , virology , intensive care medicine , immunology , malaria , outbreak , disease , chemotherapy , infectious disease (medical specialty) , cisplatin

Aim of this paper is to remind the risk of ototoxicity when using chloroquine and hydroxychloroquine, in particular as prophylactic agents against SARS-CoV-2, during the pandemic. Healthy subjects taking chloroquine and hydroxychloroquine as prophylactic agents against SARS-CoV-2, during the pandemic, should be screened periodically, at least by Otoacoustic Emissions (OAEs) in order to detect early manifestations of possible cochlear ototoxic damages.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research